Viral cardiovascular surgical diseases: global burdens, challenges and opportunities

被引:0
|
作者
Gomes, Zoya [1 ]
Lee, Grace S. [2 ]
Mesfin, Samuel [3 ]
Rocha, Rodolfo [4 ]
Vervoort, Dominique [4 ,5 ]
机构
[1] Dalhousie Univ, Fac Med, Halifax, NS B3H 4R2, Canada
[2] Univ Toronto, Temerty Fac Med, Toronto, ON M5S 1A1, Canada
[3] Addis Ababa Univ, Coll Hlth Sci, NBH1, Addis Ababa, Ethiopia
[4] Univ Toronto, Div Cardiac Surg, Toronto, ON M5S 1A1, Canada
[5] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5T 3M6, Canada
基金
加拿大健康研究院;
关键词
cardiac surgery; cardiology; cardiomyopathy; cardiovascular disease; global cardiac surgery; global health; global surgery; myocarditis; RHEUMATIC HEART-DISEASE; PARVOVIRUS B19; MYOCARDITIS; VIRUS; MORTALITY; INFECTION; DENGUE; COMPLICATIONS; INDIVIDUALS; PREVENTION;
D O I
10.1080/14796678.2024.2348382
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Globally, more than one billion people are vulnerable to neglected tropical diseases, many of which have viral origins and cardiovascular implications. Access to cardiovascular care is limited in countries where these conditions are endemic. Six billion people lack access to safe, timely and affordable cardiac surgical care, whereby over 100 countries and territories lack a single cardiac surgeon. Moreover, while clinically unique, the surgical consequences of neglected cardiovascular diseases with viral origins have been poorly described in the current literature. This review provides an overview of the global burden of viral cardiovascular disease, describes access to cardiac surgical care in regions where these conditions are endemic, and further highlights surgical consequences and considerations to manage patients requiring cardiac surgical care.
引用
收藏
页码:229 / 239
页数:11
相关论文
共 50 条
  • [1] Neglected Cardiovascular Diseases in Africa Challenges and Opportunities
    Mocumbi, Ana Olga H.
    Ferreira, Maria Beatriz
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (07) : 680 - 687
  • [2] Challenges and Opportunities in the Evaluation of Nutraceuticals in Cardiovascular Diseases
    Sharma, Abhinav
    Felker, G. Michael
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2021, 6 (01): : 22 - 24
  • [3] Atrial fibrillation: global burdens and global opportunities
    Kornej, Jelena
    Benjamin, Emelia J.
    Magnani, Jared W.
    HEART, 2021, 107 (07) : 516 - 518
  • [4] Adiponectin and metabolic cardiovascular diseases: Therapeutic opportunities and challenges
    Lei, Xiaotian
    Qiu, Sheng
    Yang, Gangyi
    Wu, Qinan
    GENES & DISEASES, 2023, 10 (04) : 1525 - 1536
  • [5] Role of Antioxidants for the Treatment of Cardiovascular Diseases: Challenges and Opportunities
    Jain, Amit K.
    Mehra, Neelesh K.
    Swarnakar, Nitin K.
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (30) : 4441 - 4455
  • [6] Exosomes based strategies for cardiovascular diseases: Opportunities and challenges
    Li, Hang
    Zhang, Jun
    Tan, Mingyue
    Yin, Yunfei
    Song, Yiyi
    Zhao, Yongjian
    Yan, Lin
    Li, Ning
    Zhang, Xianzuo
    Bai, Jiaxiang
    Jiang, Tingbo
    Li, Hongxia
    BIOMATERIALS, 2024, 308
  • [7] Global elimination of viral hepatitis and hepatocellular carcinoma: opportunities and challenges
    Chen, Chien-Jen
    GUT, 2018, 67 (04) : 595 - 598
  • [8] Opportunities, challenges, and caveats of successful molecular imaging of cardiovascular diseases
    Bodo Levkau
    Basic Research in Cardiology, 2008, 103 : 79 - 81
  • [9] Opportunities, challenges, and caveats of successful molecular imaging of cardiovascular diseases
    Levkau, Bodo
    BASIC RESEARCH IN CARDIOLOGY, 2008, 103 (02) : 79 - 81
  • [10] Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges
    Kwekkeboom, Rick F. J.
    Lew, Zhiyong
    Doevendans, Pieter A.
    Musters, Rene J. P.
    Sluijter, Joost P. G.
    CLINICAL SCIENCE, 2014, 127 (5-6) : 351 - 365